Massive after-close trades. 16.27 563,772 @ 1.161 ($654,539)16:27 10,352 @ 1.161 ($12,019)16:25 1.60M @1.115 ($1.78mil)16:16 341,635 @ 1.194 ($$407,981)
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%